UBS Group AG - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRXZ and the CUSIP is 76028H126. A total of 5 filers reported holding REPROS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$2,0000.0%404
+14.1%
0.00%
Q2 2015$2,0000.0%3540.0%0.00%
Q1 2015$2,000
+100.0%
354
+39.4%
0.00%
Q4 2014$1,0002540.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Opus Point Partners Management, LLC 98,000$597,0000.50%
PRELUDE CAPITAL MANAGEMENT, LLC 49,000$299,0000.04%
DEUTSCHE BANK AG\ 328,969$2,003,0000.00%
Tower Research Capital LLC (TRC) 2$00.00%
UBS Group AG 354$2,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders